10 employees
Attenua, Inc. is a pharmaceutical company developing antitussive (anti-cough) medications.
2015
$35M
from 4 investors over 4 rounds
Attenua, Inc. raised $35M on May 1, 2018
Investors: Omega Funds, Abingworth, Redmile Group and OrbiMed Advisors